- 全部删除
您的购物车当前为空
Terlipressin Acetate 是一种高度选择性的加压素 V1 受体激动剂,对氧和葡萄糖剥夺/再氧合 (OGD/R) 诱导的肠上皮细胞损伤 (IEC-6) 具有抗炎和抗氧化作用,可用于肝肾综合征和耐去甲肾上腺素的败血性休克的研究。

Terlipressin Acetate 是一种高度选择性的加压素 V1 受体激动剂,对氧和葡萄糖剥夺/再氧合 (OGD/R) 诱导的肠上皮细胞损伤 (IEC-6) 具有抗炎和抗氧化作用,可用于肝肾综合征和耐去甲肾上腺素的败血性休克的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 162 | In stock | |
| 5 mg | ¥ 417 | In stock | |
| 10 mg | ¥ 570 | In stock | |
| 25 mg | ¥ 987 | In stock | |
| 50 mg | ¥ 1,398 | In stock | |
| 100 mg | ¥ 2,234 | In stock |
Terlipressin Acetate 相关产品
| 产品描述 | Terlipressin Acetate, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation/re-oxygenation (OGD/R)-induced damage in intestinal epithelial cells (IEC-6).Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research. |
| 体外活性 | 在IEC-6细胞中,用25 nM terlipressin 孵育显著提高了细胞的活性、增殖以及减少了凋亡。此外,terlipressin 还能在缺氧-再氧化(OGD/R[1])条件下,抑制TNF-α和15-F2t-isoprostane的分泌。 |
| 体内活性 | 在使用小鼠非致死性肝脏缺血再灌注(IR)模型的研究中,我们发现terlipressin的给药显著减轻了IR引起的肝细胞凋亡、坏死和炎症[2]。 |
| 别名 | 醋酸特利加压素, Terlipressin acetate anhydrous |
| 分子量 | 1347.5 |
| 分子式 | C56H82N16O19S2 |
| CAS No. | 1884420-36-3 |
| Smiles | CC(O)=O.CC(O)=O.[H][C@@]1(Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)CNC(=O)CNC(=O)CN |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| Sequence | Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge: Cys4-Cys9) |
| Sequence Short | GGGCYFQNCPKG-NH2 (Disulfide bridge: Cys4-Cys9) |
| 存储 | keep away from moisture,store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 95 mg/mL (70.5 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容